FDA Drug Approvals for Cancer in 2016

This slide show highlights 2016 FDA approvals of cancer treatments, which to date include therapies for RCC, neuroendocrine tumors, Hodgkin lymphoma, CLL, sarcoma, bladder cancer, lung cancer, and breast cancer.

Source: CancerNetwork - July 29, 2016 Category: Cancer & Oncology Authors: Cancer Network Editors Source Type: news